Free Trial

OrthoPediatrics Q2 2023 Earnings Report

OrthoPediatrics logo
$22.38 -0.21 (-0.93%)
(As of 12/20/2024 05:16 PM ET)

OrthoPediatrics EPS Results

Actual EPS
-$0.19
Consensus EPS
-$0.19
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

OrthoPediatrics Revenue Results

Actual Revenue
$39.56 million
Expected Revenue
$39.11 million
Beat/Miss
Beat by +$450.00 thousand
YoY Revenue Growth
N/A

OrthoPediatrics Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Vladimir Lenin was right… (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

OrthoPediatrics Earnings Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More OrthoPediatrics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OrthoPediatrics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OrthoPediatrics and other key companies, straight to your email.

About OrthoPediatrics

OrthoPediatrics (NASDAQ:KIDS), a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

View OrthoPediatrics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings